Is combination therapy with an alphablocker and a DHT blocker better than either agent alone for long-term management of benign prostatic hypertrophy (BPH)?
Keyword(s):
2014 ◽
Vol 32
(3)
◽
pp. 133
◽
1988 ◽
Vol 79
(10)
◽
pp. 1697-1702
Keyword(s):
1984 ◽
Vol 75
(7)
◽
pp. 1141-1147
◽
1987 ◽
Vol 151
(1)
◽
pp. 51-56
◽
2018 ◽
Vol 71
(11)
◽
pp. A1790